Shetzline Michael 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed May 22, 2024
Insider Transaction Report
Form 4
Shetzline Michael
SVP, CMO, Head-Res&Drug
Transactions
- Sale
Class A Common Stock
2024-05-20$6.45/sh−16,128$104,026→ 413,719 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.